Your browser doesn't support javascript.
loading
Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.
Kreimer, A R; Ferreiro-Iglesias, A; Nygard, M; Bender, N; Schroeder, L; Hildesheim, A; Robbins, H A; Pawlita, M; Langseth, H; Schlecht, N F; Tinker, L F; Agalliu, I; Smoller, S W; Ness-Jensen, E; Hveem, K; D'Souza, G; Visvanathan, K; May, B; Ursin, G; Weiderpass, E; Giles, G G; Milne, R L; Cai, Q; Blot, W J; Zheng, W; Weinstein, S J; Albanes, D; Brenner, N; Hoffman-Bolton, J; Kaaks, R; Barricarte, A; Tjønneland, A; Sacerdote, C; Trichopoulou, A; Vermeulen, R C H; Huang, W-Y; Freedman, N D; Brennan, P; Waterboer, T; Johansson, M.
Afiliação
  • Kreimer AR; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA. Electronic address: kreimera@mail.nih.gov.
  • Ferreiro-Iglesias A; Genetic Epidemiology Group (GEP), International Agency for Research on Cancer (IARC), Lyon, France.
  • Nygard M; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
  • Bender N; Infections and Cancer Epidemiology, Research Program Infection, Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schroeder L; Infections and Cancer Epidemiology, Research Program Infection, Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hildesheim A; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.
  • Robbins HA; Genetic Epidemiology Group (GEP), International Agency for Research on Cancer (IARC), Lyon, France.
  • Pawlita M; Infections and Cancer Epidemiology, Research Program Infection, Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Langseth H; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
  • Schlecht NF; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx.
  • Tinker LF; Public Health Sciences, Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, USA.
  • Agalliu I; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx.
  • Smoller SW; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx.
  • Ness-Jensen E; HUNT Research Center, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Levanger, Norway.
  • Hveem K; HUNT Research Center, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Levanger, Norway.
  • D'Souza G; Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
  • Visvanathan K; Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
  • May B; Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
  • Ursin G; Cancer Registry of Norway, Institute of Population-Based Cancer Research, Majorstuen, Oslo; Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
  • Weiderpass E; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; Genetic Epidemiology Group, Folkhälsan Research Center, and Faculty of Medicine, Helsinki Uni
  • Giles GG; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Parkville; School of Public Health and Preventive Medicine, Monash University Faculty of Medicine, Nursin
  • Milne RL; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Parkville; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton,
  • Cai Q; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, USA.
  • Blot WJ; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, USA.
  • Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, USA.
  • Weinstein SJ; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.
  • Albanes D; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.
  • Brenner N; Infections and Cancer Epidemiology, Research Program Infection, Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hoffman-Bolton J; Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
  • Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Barricarte A; Navarra Public Health Institute, Pamplona; Navarra Institute for Health Research (IdiSNA), Pamplona; CIBER Epidemiology and Public Health CIBERESP, Madrid, Spain.
  • Tjønneland A; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Sacerdote C; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
  • Trichopoulou A; Hellenic Health Foundation, Athens, Greece.
  • Vermeulen RCH; Institute for Risk Assessment Sciences, Utrecht University; Julius Centre for Public Health Sciences and Primary Care, Utrecht University Medical Centre, Utrecht, the Netherlands.
  • Huang WY; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.
  • Freedman ND; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.
  • Brennan P; Genetic Epidemiology Group (GEP), International Agency for Research on Cancer (IARC), Lyon, France.
  • Waterboer T; Infections and Cancer Epidemiology, Research Program Infection, Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Johansson M; Genetic Epidemiology Group (GEP), International Agency for Research on Cancer (IARC), Lyon, France. Electronic address: johanssonm@iarc.fr.
Ann Oncol ; 30(8): 1335-1343, 2019 08 01.
Article em En | MEDLINE | ID: mdl-31185496

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Orofaríngeas / Infecções por Papillomavirus / Papillomavirus Humano 16 / Carcinoma de Células Escamosas de Cabeça e Pescoço / Anticorpos Antivirais Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Orofaríngeas / Infecções por Papillomavirus / Papillomavirus Humano 16 / Carcinoma de Células Escamosas de Cabeça e Pescoço / Anticorpos Antivirais Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article